A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Las Vegas is an emerging hub for clinical trials, benefiting from its growing healthcare network and innovative research institutions. Prominent centers such as the Cleveland Clinic Lou Ruvo Center for Brain Health, University Medical Center of Southern Nevada, and the Nevada Cancer Institute are leading the way in advancing medical research, driving innovation across various fields.
Why choose Las Vegas for clinical trials?
Las Vegas presents distinct advantages for those considering participation in clinical trials. The city’s dynamic and diverse population allows for a wide range of participants, which enhances the accuracy and applicability of research outcomes.
Choosing to participate in a clinical trial in Las Vegas not only gives you access to advanced treatments and therapies but also supports vital medical research in a city renowned for its rapid growth and development. The supportive research environment and commitment to innovation in Las Vegas make it an ideal location for contributing to significant advancements in healthcare.
Common conditions studied in Las Vegas
Las Vegas is a notable center for clinical research, particularly due to its advanced facilities and diverse patient population.
Neurological disorders
The Cleveland Clinic Lou Ruvo Center for Brain Health stands out for its groundbreaking research in neurological disorders. It is renowned for its work on Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS).
This center, and other institutions in Las Vegas focus on developing innovative diagnostic tools and treatment strategies, including novel drug therapies, lifestyle interventions, and experimental procedures designed to slow disease progression and improve patient quality of life.
Cancer
The Nevada Cancer Institute, among other local institutions, plays a significant role in cancer research. Trials here explore a wide range of cancers, such as lung, breast, and prostate cancers.
Researchers investigate advanced oncology treatment options, including targeted therapies that attack cancer cells specifically, immunotherapies that harness the body’s immune system to fight cancer, and precision medicine approaches that tailor treatments based on genetic and molecular profiles of tumors.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Cardiovascular disease
Clinical research in cardiovascular diseases in Las Vegas covers conditions like heart disease, hypertension, and heart failure. Trials often focus on evaluating new pharmacological treatments, innovative surgical techniques, and interventional procedures.
As heart disease is the leading cause of death in Las Vegas’ parent state, Nevada, research also includes lifestyle modification studies aimed at improving cardiovascular health and preventing disease progression.
Autoimmune diseases
Research into autoimmune diseases such as rheumatoid arthritis and lupus is prominent in Las Vegas. Clinical trials in this area test new biologic therapies and other medications designed to modify the immune system’s activity and alleviate symptoms. These trials are crucial for developing more effective treatments that target the underlying mechanisms of autoimmune conditions.
Metabolic disorders
Diabetes and obesity are key focus areas for clinical trials in Las Vegas. Studies explore new medications, including those that target blood sugar regulation and weight management, as well as lifestyle interventions and combined approaches for managing these conditions. Research efforts aim to improve treatment efficacy and patient outcomes for these widespread metabolic disorders.
Infectious diseases
Las Vegas also conducts significant research into infectious diseases such as HIV/AIDS and hepatitis. As a popular tourist hub welcoming millions of visitors every year, infectious diseases can spread rapidly through the city, which makes research even more crucial.
Clinical trials in this field investigate new antiviral drugs, vaccines, and treatment strategies aimed at improving infection management and prevention. The city's growing expertise in this area is essential for advancing care and finding innovative solutions to complex infectious disease challenges.
Chronic conditions
Las Vegas’s clinical research on chronic conditions is characterized by a comprehensive approach that includes a variety of trials and interventions. The city’s focus on cardiovascular diseases, COPD, chronic kidney disease, and rheumatoid arthritis involves testing new medications, exploring innovative treatments, and implementing lifestyle and behavioral interventions. This multifaceted approach aims to enhance the management of chronic conditions and improve long-term health outcomes for patients.
Local regulations and guidelines
In Las Vegas, clinical trials operate under a robust framework of regulations designed to ensure both participant safety and research integrity. Compliance with federal guidelines from the FDA and the Office for Human Research Protections (OHRP) is mandatory, encompassing standards such as Good Clinical Practice (GCP), informed consent, and adverse event reporting.
Each trial must undergo rigorous review by an Institutional Review Board (IRB) at research institutions like the Cleveland Clinic Lou Ruvo Center for Brain Health and the Nevada Cancer Institute, which scrutinize the ethical aspects of the study. Additionally, researchers must adhere to state regulations enforced by the Nevada Department of Health and Human Services. This includes strict compliance with HIPAA to safeguard participant data privacy and security.
Benefits of participating in clinical trials
Participating in a clinical trial offers the unique advantage of early access to cutting-edge treatments and therapies before they become widely available. Individuals benefit from exceptional care provided by top healthcare professionals, who deliver personalized support and thorough monitoring throughout the study.
Engaging in these trials is crucial for advancing medical research, which can lead to significant breakthroughs in treatments and preventive measures. By enrolling, participants play a vital role in progressing scientific knowledge, contributing to future improvements in healthcare outcomes for others.
How to enroll in a clinical trial in Las Vegas
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.